Clinical Trial Update: Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of chemoradiotherapy after neoadjuvant cisplatin and docetaxel in nasopharyngeal carcinoma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Head and Neck Neoplasms | Phase 4 | Status: COMPLETED